Evidence map›Paper›PMID 11826009›Full record

ArticleJournal of clinical microbiology2002

Human infections due to Mycobacterium lentiflavum.

Enrico Tortoli, Alessandro Bartoloni, Maria Luigia Erba, Egle Levrè, Natalia Lombardi, Antonia Mantella, Lorenzo Mecocci

Abstract readCase Reports
In one paragraph

Article in Journal of clinical microbiology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 44 citations in OpenAlex.

  1. [Generalized lynphadenopathy and disseminated Mycobacterium lentiflavum infection in an immunosuppressed patient].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Article
  2. Pseudo-outbreak ofInfection control and hospital epidemiology · 2023
    Article
  3. Article
  4. Article
  5. Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients.Annals of clinical microbiology and antimicrobials · 2014
    Article
  6. Article
  7. Article
  8. Article
  9. Mycobacterium lentiflavum, a recently identified slow-growing mycobacterial species: clinical significance in immunosuppressed cancer patients and summary of reported cases of infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2005
    Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Enrico TortoliRegional Reference Center for Mycobacteria, Microbiology and Virology Laboratory, Careggi Hospital, Italy. e.tortoli@libero.it
Alessandro Bartoloni
Maria Luigia Erba
Egle Levrè
Natalia Lombardi
Antonia Mantella
Lorenzo Mecocci
University of Florence · ITUniversity of Pisa · ITOspedale Santa Maria Annunziata · ITSt. Anna Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three cases of human disease due to Mycobacterium lentiflavum are reported. In the first, the mycobacterium was responsible for chronic pulmonary disease in an elderly woman; in the second, it gave rise to cervical lymphadenitis in a child; and in the third, it caused a liver abscess in a young AIDS patient.

Indexed as

Child, PreschoolChronic DiseaseFemaleHumansLiver AbscessLung DiseasesMaleMiddle AgedMycobacteriumMycobacterium InfectionsTuberculosis, Lymph Node

Identifiers

PMID11826009
PMCPMC153347
OpenAlexW2091396890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.